Financial anchor year: FY25. Margin and revenue are as filed for FY25. Balance-sheet measures (current ratio, equity financing, days in A/R) use FY24, the latest filing whose balance sheet reconciled as filed. Every tile below states its own fiscal year; nothing is carried forward or estimated.
The read
A dialysis facility in TN. It ran an operating surplus of 25.8% in FY25 on $4.4M of operating revenue. It held 394 days of cash on hand. Operating margin improved from -31.4% in FY20 to 25.8% in FY25.
Operating margin · FY25
+25.8%
Astrelis calculation · as-filed inputs
not ranked: no valid same-year pool for this metric (needs n ≥ 25 and ≥ 50% of the cohort's filers at FY25)
Days cash on hand · FY25
394d
all sources
Astrelis calculation · as-filed inputs
not ranked: no valid same-year pool for this metric (needs n ≥ 25 and ≥ 50% of the cohort's filers at FY25)
Total operating revenue · FY25
$4.4M
Astrelis calculation · as-filed inputs
not ranked: no valid same-year pool for this metric (needs n ≥ 25 and ≥ 50% of the cohort's filers at FY25)
Total margin · incl. nonoperating · FY25
+25.8%
Astrelis calculation · as-filed inputs
not ranked: no valid same-year pool for this metric (needs n ≥ 25 and ≥ 50% of the cohort's filers at FY25)
The money
$ thousands · HCRIS cost-report basis · as filed, QA-gated
Ratios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio computes only when every input is reported in the filing (otherwise its cell states which input is Not reported in source); a year whose balance sheet does not reconcile is labeled, and its derived ratios read Astrelis calculation unavailable. Not audited by Astrelis.
Operating margin
+25.8% (FY25)
Operating income ÷ total operating revenue
Astrelis calculation · HCRIS WS G-3
Total margin
+25.8% (FY25)
Net income ÷ total revenue incl. nonoperating
Astrelis calculation · HCRIS WS G-3
Days cash on hand
394d (FY25)
Cash & investments ÷ daily operating expense
Astrelis calculation · HCRIS WS G / G-3
Current ratio
20.33× (FY24)
Total current assets ÷ current liabilities
Astrelis calculation · HCRIS WS G
Equity financing ratio
95% (FY24)
Total net assets ÷ total assets
Astrelis calculation · HCRIS WS G
Days in net patient A/R
-39d (FY24) — outside expected range; shown at the chart boundary and included in peer statistics
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
Astrelis calculation · HCRIS WS G / G-3
$ in thousands
Line item
FY23
FY24
FY25
Patient revenue
3,265
3,851
4,421
Total operating revenue
3,265
3,851
4,421
Total operating expenses
3,526
3,404
3,281
Operating income
(261)
448
1,140
Operating margin %
-8.0%
+11.6%
+25.8%
Other non-operating, net
0
0
0
Net income
(261)
448
1,140
Net income %
-8.0%
+11.6%
+25.8%
— = Not reported in source for that year.
HCRIS CMS-265 cost report · $ thousands · FY20–FY25 · operating revenue reflects net patient service revenue · FY20–21 may include COVID-era relief funding
Display states.FY22 · Days cash on hand: -692 days — Astrelis calculation · outside expected range; shown at the chart boundary and included in peer statistics (outside the 0–1,500-day expected range — a valid filing can produce this; the pool absorbs it)FY23 · Days cash on hand: -1,100 days — Astrelis calculation · outside expected range; shown at the chart boundary and included in peer statistics (outside the 0–1,500-day expected range — a valid filing can produce this; the pool absorbs it)
How it operates
quality & operational context · CMS public reporting
The metrics this dialysis facility type is judged on: care quality, patient experience, and scale. Each is labeled by provenance class and public source; descriptive context only, never a ranking or adequacy claim. Provenance labels: Reported value is copied from the named public source; Astrelis calculation is a formula applied to unchanged reported inputs, with the formula shown; Illustrative estimate is a benchmark gap, multiplier, or scenario — never a measurement.
Total treatments
7,233
Reported value2025
HCRIS CMS-265
Cost per treatment ($)
453.62
Astrelis calculation2025
HCRIS CMS-265
Net revenue per treatment ($)
611.24
Astrelis calculation2025
HCRIS CMS-265
Trajectory
Cost-report basis · 6 reporting years
Operating margin
Days cash on hand
State context
Tennessee
County-level statistics: linkage not established— this record's county mapping is not verified in the resolved spine, and we never place a facility in a county by guesswork. State-level context appears here once a state aggregate layer lands.
A facility-specific dollar comparison cannot be calculated because a valid same-year peer pool was not reported. The report still includes all available facility measures, peer benchmarks, and a source-coverage inventory.
Report coverage: Limited Facility Benchmark. 7 of 10 facility measures available from public sources. The report covers the available measures against their peer benchmarks; measures the public record does not carry become findings. Coverage is disclosed here before you reserve, and thin data is never a decline reason. The refund guarantee stands: if we cannot deliver the published scope, you pay nothing.
The Board Briefing
Your facility and its world, board-ready. Measures the public record does not carry become findings, never a decline reason.
$1,000delivered within 2 business days of invoice
Reservation: invoice after coverage confirmation. No payment is collected on this site.
